[6] Some patients find it helpful to imagine a clock face on their abdomen or to keep a simple diary noting which site was used on which date
Tirzepatide is a dual GIP/GLP-1 receptor agonist, meaning it mimics the activity of two incretin hormones your body naturally produces: glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1)
1 GLP-1 receptor agonists are a class of medications that mimic and amplify these effects
For more evidence-based peptide comparisons and the latest on retatrutide's progress, explore the full library at Helpful Tools Related Articles Retatrutide vs Tirzepatide Compared Retatrutide vs tirzepatide compared: 28.7% vs 22.5% weight loss, triple vs dual agonist mechanism, side effects, dosing, cost, and FDA status
It also comes as a once-weekly injection
The tirzepatide is the same amount regardless